Chinook Therapeutics Inc (NASDAQ:KDNY)
| 19.75 Delayed Data As of 4:00pm ET |  +0.09 / +0.46%Today’s Change | 10.48 Today|||52-Week Range 23.86 | +21.09% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Samsara Biocapital Llc Director |  Buy | 11/15/2021 | 1,215,000 | $14.00 | $17.0M | +21.21% |
Versant Venture Management Llc Director |  Sale | 1/03/2022 | 600,000 | $16.00 | $9.6M | +17.80% |
Versant Venture Management Llc | Sale | 1/03/2022 | 600,000 | $16.00 | $9.6M | +17.80% |
Samsara Biocapital Llc Director | Buy | 5/27/2022 | 570,000 | $14.00 | $8.0M | +27.50% |
Versant Venture Management Llc Director | Sale | 1/03/2022 | 308,000 | $16.00 | $4.9M | +17.80% |
Versant Venture Management Llc | Sale | 1/03/2022 | 308,000 | $16.00 | $4.9M | +17.80% |
Versant Venture Management Llc Director | Sale | 1/03/2022 | 92,000 | $16.00 | $1.5M | +17.80% |
Versant Venture Management Llc | Sale | 1/03/2022 | 92,000 | $16.00 | $1.5M | +17.80% |
Frohlich Tom /versant Ventures/ Chief Operating Officer | Sale | 11/05/2021 | 15,000 | $14.00 | $210.0K | +23.18% |
Frohlich Tom /versant Ventures/ Chief Operating Officer | Sale | 11/08/2021 | 13,770 | $15.17 | $208.9K | +38.55% |
Page of 5